Submission of financial result for the quarter ended December 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories reported Q3 FY26 revenue from operations of Rs. 2,156.42 lakhs, down about 6% YoY from Rs. 2,298.61 lakhs. For the nine months ended December 2025, revenue fell sharply by roughly 32% YoY to Rs. 5,942.04 lakhs versus Rs. 8,687.06 lakhs a year ago. Profit after tax for the quarter stood at Rs. 277.55 lakhs (vs Rs. 614.45 lakhs YoY), while nine-month PAT declined about 48% to Rs. 1,115.74 lakhs from Rs. 2,132.86 lakhs. Operating profit margins also compressed meaningfully — quarterly PBT before tax fell from Rs. 831.45 lakhs to Rs. 369.55 lakhs. The statutory auditor issued an unqualified limited review report with no qualifications or emphasis of matter.
Sharp declines in both top line and bottom line, along with margin compression, signal meaningful operational stress for shareholders; the stock may face pressure unless the company demonstrates a turnaround in subsequent quarters.